Elevated pretreatment serum concentration of YKL-40-An independent prognostic biomarker for poor survival in patients with metastatic nonsmall cell lung cancer.

Thöm, Ina; Andritzky, Birte; Schuch, Gunter; Burkholder, Iris; Edler, Lutz; Johansen, Julia S; Bokemeyer, Carsten; Schumacher, Udo; Laack, Eckart

Thöm, Ina; Andritzky, Birte; Schuch, Gunter; Burkholder, Iris; Edler, Lutz; Johansen, Julia S; Bokemeyer, Carsten; Schumacher, Udo; Laack, Eckart.

Affiliation

Thöm I; Department of Oncology, Hematology, and Bone Marrow Transplantation with Section Pneumology, Hubertus Wald Tumor Center, University Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. i.thoem@uke.uni-hamburg.de

Cancer ; 116(17): 4114-21, 2010 Sep 01.

Article in En | MEDLINE | ID: mdl-20564116

Subject(s)

Biomarkers, Tumor/blood; Carcinoma, Non-Small-Cell Lung/blood; Glycoproteins/blood; Lectins/blood; Adipokines; Adult; Aged; Carcinoma, Non-Small-Cell Lung/mortality; Carcinoma, Non-Small-Cell Lung/pathology; Chitinase-3-Like Protein 1; Disease-Free Survival; Female; Humans; Male; Middle Aged; Neoplasm Metastasis; Prognosis

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Glycoproteins / Biomarkers, Tumor / Carcinoma, Non-Small-Cell Lung / Lectins Type of study: Prognostic_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Cancer Year: 2010 Document type: Article Affiliation country: Germany

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google